161Tb-PSMA-I&T and177Lu-PSMA-I&T treatment in T23 and ST4787 prostate cancer cell lines - a model representative of177Lu-PSMA-resistant prostate cancer phenotype

被引:0
|
作者
Kirienko, M. [1 ]
Jachetti, E. [1 ]
Sulsenti, R. [1 ]
Pascali, C. [1 ]
Bogni, A. [1 ]
Colombo, M. [1 ]
Seregni, E. [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0010
引用
收藏
页码:S434 / S435
页数:2
相关论文
共 50 条
  • [31] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [32] Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure (vol 58, pg 381, 2024)
    Abdlkadir, Ahmed Saad
    Abufara, Alaa
    Al-Ibraheem, Akram
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 94 - 94
  • [33] RADIOLIGAND THERAPY WITH 177LU-PSMA-I&T IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: ONCOLOGICAL OUTCOMES AND TOXICITY PROFILE
    Demirkol, Mehmet Onur
    Esen, Baris
    Sen, Melis
    Ucar, Burcu
    Kurtuldu, Sevgilay
    Mandel, Nil Molinas
    Bavbek, Sevil
    Falay, Okan
    Tilki, Derya
    Esen, Tarik
    JOURNAL OF UROLOGY, 2023, 209 : E125 - E126
  • [34] From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
    Al-Ibraheem, Akram
    Abdlkadir, Ahmed Saad
    Sweedat, Deya' Aldeen
    Maus, Stephan
    Al-Rasheed, Ula
    Salah, Samer
    Khriesh, Fadi
    Juaidi, Diyaa
    Abu Dayek, Dina
    Istatieh, Feras
    Anwar, Farah
    Asrawi, Aisha
    Abufara, Alaa
    Al-Rwashdeh, Mohammad
    Abu-Hijlih, Ramiz
    Sharaf, Baha'
    Ghanem, Rami
    Abdel-Razeq, Hikmat
    Mansour, Asem
    CANCERS, 2024, 16 (11)
  • [35] Treatment of liver metastases of castration resistant prostate cancer with 177Lu-PSMA-617 and SIRT
    Seifert, Robert
    Boegemann, Martin
    Kahler, Michael
    Dittmann, Matthias
    Weckesser, Matthias
    Rahbar, Kambiz
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [36] Prognostic Performance of RECIP 1.0 Based on [18F]PSMA-1007 PET in Prostate Cancer Patients Treated with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Huttmann, Thomas
    Seitz, Anna Katharina
    Kubler, Hubert
    Serfling, Sebastian E.
    Higuchi, Takahiro
    Telburg, Wiebke Schlo euro
    Michalski, Kerstin
    Gafita, Andrei
    Rowe, Steven P.
    Pomper, Martin G.
    Buck, Andreas K.
    Werner, Rudolf A.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 560 - 565
  • [37] The First Experience on Lutetium (lu)-177 Prostate Specific Antigen (PSMA) Treatment in Castration Resistant Prostate Cancer Patients
    Soydal, C.
    Ozkan, E.
    Nak, D.
    Kucuk, O. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S415 - S415
  • [38] Significance of interim 18F-PSMA-1007 PET/CT for early prediction of 177Lu-PSMA-I&T treatment effect in metastatic castration-resistant prostate cancer patients
    Cheung, S.
    Chen, S.
    Wong, Y.
    Yip, Y.
    Ho, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S178 - S179
  • [39] Therapy of Metastasized Prostate Cancer Using a Lu-177 Labeled PSMA Inhibitor (I&T): First Dosimetric Results in Patients
    Schuchardt, C.
    Wiessalla, S.
    Ozkan, A.
    Kulkarni, H. R.
    Shahinfar, M.
    Sayeg, M.
    Weineisen, M.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S99 - S99
  • [40] Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T
    Karimzadeh, Amir
    Soeiro, Paula
    Feuerecker, Benedikt
    Hecker, Charlotte-Sophie
    Knorr, Karina
    Heck, Matthias M.
    Tauber, Robert
    Alessandria, Calogero D. '
    Weber, Wolfgang A.
    Eiber, Matthias
    Rauscher, Isabel
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1765 - 1771